| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/05/1998 | CA2262002A1 Hppd gene and inhibitors |
| 02/05/1998 | CA2261991A1 Preparation of immunostimulating agents based on propionibacteria |
| 02/05/1998 | CA2261990A1 Recombinant pox virus for immunization against tumor-associated antigens |
| 02/05/1998 | CA2261823A1 Desaturase antigen of mycobacterium tuberculosis |
| 02/05/1998 | CA2261775A1 Isolated spinach rubisco large subunit n-methyltransferase |
| 02/05/1998 | CA2261607A1 Homogeneous diagnostic assay method utilizing simultaneous target and signal amplification |
| 02/05/1998 | CA2261581A1 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | CA2261580A1 Antimicrobial peptides |
| 02/05/1998 | CA2261575A1 Novel human macrophage antigen |
| 02/05/1998 | CA2261563A1 Human proteolipid |
| 02/05/1998 | CA2261561A1 Modified tomato mottle geminivirus coat protein gene |
| 02/05/1998 | CA2261164A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/05/1998 | CA2261155A1 Biosynthetic gene ddl from streptococcus pneumoniae |
| 02/05/1998 | CA2261071A1 Assembly-deficient herpesvirus vaccine |
| 02/05/1998 | CA2260740A1 A novel human mrna editing enzyme |
| 02/05/1998 | CA2259948A1 Use of a lestr/fusin/cxcr4 receptor ligand chemokine (sdf-1) for treating or preventing hiv-type viral infection |
| 02/05/1998 | CA2259924A1 Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use |
| 02/05/1998 | CA2253521A1 Synthesis of .beta.-lactam antibacterials using soluble side chain esters and enzyme acylase |
| 02/05/1998 | CA2232975A1 The nuca protein of haemophilus influenzae and the gene encoding that protein |
| 02/04/1998 | EP0822258A2 Vector for positive selection, based on the cap gene, the pCAPs vector and its applications |
| 02/04/1998 | EP0822257A2 Peptidoglycan biosynthetic gene murA from Streptococcus pneumonaie |
| 02/04/1998 | EP0822256A2 Modified thermostable DNA polymerase, and DNA polymerase composition for nucleic acid amplification |
| 02/04/1998 | EP0822255A2 CHO (Chinese Hamster Ovary) glycosylated antibodies and their use in therapy |
| 02/04/1998 | EP0821741A1 Glucose-inducible recombinant viral vector |
| 02/04/1998 | EP0821740A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations |
| 02/04/1998 | EP0821739A1 An adenovirus helper-virus system |
| 02/04/1998 | EP0821738A2 Repertoire cloning process, products derived therefrom and uses for said products |
| 02/04/1998 | EP0821737A1 NUCLEOTIDE SEQUENCE OF THE HAEMOPHILUS INFLUENZAE Rd GENOME, FRAGMENTS THEREOF, AND USES THEREOF |
| 02/04/1998 | EP0821736A1 Bacteriocins |
| 02/04/1998 | EP0821735A1 Helicobacter pylori cagi region |
| 02/04/1998 | EP0821734A2 Use of an "immunodeficiency-virus suppressing lymphokine (isl)" to inhibit the replication of viruses, in particular of retroviruses |
| 02/04/1998 | EP0821733A2 Genetic markers for breast and ovarian cancer |
| 02/04/1998 | EP0821732A1 Altered polypeptides with increased half-life |
| 02/04/1998 | EP0821731A1 Modulator of neuronal cell response to inhibition by cns myelin |
| 02/04/1998 | EP0821730A1 Chimeric receptors for regulating cellular proliferation and effector function |
| 02/04/1998 | EP0821729A1 Structure-based designed herbicide resistant products |
| 02/04/1998 | EP0821728A1 Tie-2 ligands, methods of making and uses thereof |
| 02/04/1998 | EP0821698A1 Protective helicobacter antigens |
| 02/04/1998 | EP0821695A1 Antibody purification by low-ph hydrophobic interaction chromatoggraphy |
| 02/04/1998 | EP0821694A1 Conotoxin peptides |
| 02/04/1998 | EP0821693A1 Novel human cytomegalovirus dna sequences |
| 02/04/1998 | EP0821619A1 Methods and apparatus for the generation of chemical libraries |
| 02/04/1998 | EP0821591A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same |
| 02/04/1998 | EP0821583A1 Dna vaccines against rotavirus infections |
| 02/04/1998 | EP0767605A4 Plant virus resistance gene and methods |
| 02/04/1998 | EP0753992A4 Antiviral transgenic plants, vectors, cells and methods |
| 02/04/1998 | EP0708827B1 Purification method and apparatus |
| 02/04/1998 | EP0694044A4 Method and product for regulating cell responsiveness to external signals |
| 02/04/1998 | EP0652967B1 Self-assembling replication defective hybrid virus particles |
| 02/04/1998 | EP0651800B1 Basophil granule proteins |
| 02/04/1998 | EP0633944A4 Method of multiplex ligase chain reaction. |
| 02/04/1998 | EP0568537B1 Genetic modification of endothelial cells |
| 02/04/1998 | EP0506821B1 Hybrid protein c |
| 02/04/1998 | EP0500791B1 The design and construction of non-infectious human retroviral mutants deficient in genomic rna |
| 02/04/1998 | EP0460072B1 Human elastase inhibitor |
| 02/04/1998 | EP0383837B1 Alveolar surfactant proteins |
| 02/04/1998 | CN1172511A Method and compositions for treating cellulose containing fabrics using truncated cellulase enzyme compositions |
| 02/04/1998 | CN1172503A Toxins from wasp bracon hebetor |
| 02/04/1998 | CN1172502A In vivo mutations and polymorphisms in 17 q -linked breast and ovarian cancer susceptibility gene |
| 02/04/1998 | CN1172501A Method for disigning alpha-amylase mutants with predetermined properties |
| 02/04/1998 | CN1172500A Amylase variants |
| 02/04/1998 | CN1172435A Use of non-mammalian DNA virus to express exogenous gene in mammalian cell |
| 02/04/1998 | CN1172416A Enhanced carotenoid accumulation in storge organs of genetically engineered plants |
| 02/04/1998 | CN1172164A Promoting human lung glandular cancer cell differentiation CDNa and its eucaryon express carrier and application |
| 02/04/1998 | CN1172163A Promoting human lung glandular cancer cell differentiation CDNA and its eucaryon express carrier and application |
| 02/04/1998 | CN1172162A Promoting human lung glandular cancer cell differentiation CDNA and its eucaryon expressing carrier and application |
| 02/04/1998 | CN1172161A Akaweiki transferase and its preparation and use |
| 02/04/1998 | CN1172116A Aprotinin variants having improved properties |
| 02/04/1998 | CN1037278C Method for producing exogenous genes products using tussah chrysalis |
| 02/03/1998 | US5714667 Mice lacking expression of CTLA-4 receptor |
| 02/03/1998 | US5714666 Measurement of intracellular calcium using bioluminescent apoaequorin expressed in mammalian cells |
| 02/03/1998 | US5714595 Mechanism-based screen for retinoid X receptor agonists and antagonists |
| 02/03/1998 | US5714594 cDNA cloning and expression of human liver estrogen sulfotransferase |
| 02/03/1998 | US5714593 Vaccines, medical diagnosis |
| 02/03/1998 | US5714588 Enhancement of cellular attachment using H3 protein |
| 02/03/1998 | US5714585 Antibodies that are immunoreactive with interleukin-7 |
| 02/03/1998 | US5714581 Antitumor agents, leukemia treatment |
| 02/03/1998 | US5714578 Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body |
| 02/03/1998 | US5714575 Nucleic acids sequence, stress-induced proteins and uses thereof |
| 02/03/1998 | US5714474 Production of enzymes in seeds and their use |
| 02/03/1998 | US5714465 Method of inhibiting tumor cell dissemination with a metalloproteinase inhibitor |
| 02/03/1998 | US5714383 Method and reagent for treating chronic myelogenous leukemia |
| 02/03/1998 | US5714382 Isolated dna encoding feline interferon precursor having specified amino acid sequence |
| 02/03/1998 | US5714381 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
| 02/03/1998 | US5714377 Modified fungal cells and method for producing recombinant products |
| 02/03/1998 | US5714376 For products with specific anticoagulant activity |
| 02/03/1998 | US5714374 Genetically engineered viruses comprising human rhinovirus incorporated with chimeric regions derived from an orthomyxovirus, picornavirus, retrovirus, neoplasm, parasite or bacterium; vaccines; immunoassay |
| 02/03/1998 | US5714371 Method for refolding insoluble aggregates of hepatitis C virus protease |
| 02/03/1998 | US5714365 Sucrose phosphate synthetase isolated from maize |
| 02/03/1998 | US5714362 Human superoxide dismutase cDNA |
| 02/03/1998 | US5714359 Apparatus and method for electrostatic endothelial cell seeding in a vascular prosthesis |
| 02/03/1998 | US5714355 Biologically pure culture of mutant microorganism |
| 02/03/1998 | US5714353 Safe vectors for gene therapy |
| 02/03/1998 | US5714352 Genetic engineering |
| 02/03/1998 | US5714350 Genetic engineering to form mutant antibodies by eliminating a variable site of glycosylation |
| 02/03/1998 | US5714349 Cultivating escherichia coli transformed with plasmid under conditions suitable for expression of human parathyroid hormone |
| 02/03/1998 | US5714348 Culturing, supplying glycerol to inoculated fermentation broth at a rate proportional to oxygen uptake rate of microorganism until a threshold value is reached, then providing glycerol to broth at constant supply until finish |
| 02/03/1998 | US5714347 Preparation of recombinant ubiquitin cross-reactive protein (UCRP) with improved bioactivity |
| 02/03/1998 | US5714346 Process for production of human growth hormone using Bacillus Brevis |
| 02/03/1998 | US5714345 Cointroducing into embryonic mammalian cells a dna sequence encoding the pharmaceutical protein of interest and also a regulatory dna sequence from a mammary gland specific gene; efficiency |